Creative Planning
QNTM

Creative Planning’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Creative Planning’s Portfolio QNTM Stock Details QNTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-211
Closed -$11K – 2631
2022
Q3 		$11K Hold
211
– – ﹤0.01% 2226
2022
Q2 		$11K Buy
+211
New +$12.7K ﹤0.01% 2190

Other funds holding QNTM

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Creative Planning's QNTM Position: Q4 2022 in Review

Creative Planning sold out of Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q4 2022, closing a stake of 211 shares — an estimated $11K sold.

Creative Planning first reported a position in QNTM in Q2 2022 and held it in 2 quarters. The position peaked at $11K in Q3 2022. 14 funds tracked by Wall St. Rank hold QNTM as of Q4 2022.

  • Creative Planning reported no remaining Quantum Biopharma Class B Subordinate Voting Shares position as of Q4 2022 after selling out during the quarter.
  • Creative Planning sold 211 Quantum Biopharma Class B Subordinate Voting Shares shares in Q4 2022, an estimated $11K.
  • Creative Planning first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q2 2022 and held it in 2 quarters.
  • Creative Planning's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $11K in Q3 2022.
  • 14 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q4 2022.

Based on Creative Planning's 13F filing for Q4 2022, filed 10 Feb 2023.